• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区鲍曼不动杆菌临床分离株对环丙沙星、氨苄西林/舒巴坦和亚胺培南耐药机制的研究。

Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.

机构信息

Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Int J Antimicrob Agents. 2010 Apr;35(4):382-6. doi: 10.1016/j.ijantimicag.2009.12.009. Epub 2010 Feb 6.

DOI:10.1016/j.ijantimicag.2009.12.009
PMID:20138741
Abstract

Nosocomial infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have been increasing in recent years, posing a threat to public health worldwide. The susceptibility to eight antimicrobial agents of 35 clinical A. baumannii isolates from Taiwan was tested. Isolates were examined by polymerase chain reaction (PCR) and sequencing for beta-lactamase genes and mutations in the gyrA and parC genes. Expression of AdeB, an efflux pump protein, was evaluated by real-time quantitative PCR. The level of adeB expression correlated with resistance to ciprofloxacin and ampicillin/sulbactam in A. baumannii isolates. Almost all isolates with full resistance to ciprofloxacin had both high adeB expression and point mutations in parC and gyrA, but 4 intermediate-resistant isolates had only high adeB expression without point mutations in gyrA or parC, in contrast to 18 susceptible isolates with low adeB expression and without mutations in gyrA or parC. Sixteen isolates (45.7%) carrying a type 1 integron were MDR as well as being more resistant to imipenem, amikacin, gentamicin, ceftazidime or cefepime than those without the integron. The class 1 integron in A. baumannii carried different resistance gene cassettes, including 5'CS-bla(IMP-1)-aadA4-3'CS, 5'CS-aacA4-aadA1-3'CS and 5'CS-aacC1-aadA1-3'CS. In conclusion, expression of the adeB gene was associated with resistance to ciprofloxacin and ampicillin/sulbactam in A. baumannii. Multiple mutations in gyrA and parC also played a role in ciprofloxacin resistance. The major metallo-beta-lactamase contributing to imipenem resistance in A. baumannii in Taiwan was bla(IMP-1), which was carried by the class 1 integron. The class 1 integron was associated with the MDR phenotype in A. baumannii.

摘要

近年来,耐多药(MDR)鲍曼不动杆菌引起的医院感染不断增加,对全球公共健康构成威胁。检测了来自台湾的 35 株临床鲍曼不动杆菌分离株对 8 种抗菌药物的敏感性。通过聚合酶链反应(PCR)和测序检测β-内酰胺酶基因和 gyrA 和 parC 基因的突变。通过实时定量 PCR 评估 AdeB,一种外排泵蛋白的表达。A. baumannii 分离株中 adeB 表达水平与对环丙沙星和氨苄西林/舒巴坦的耐药性相关。几乎所有对环丙沙星完全耐药的分离株均具有高 adeB 表达和 parC 和 gyrA 中的点突变,但 4 株中度耐药的分离株仅具有高 adeB 表达,而 gyrA 或 parC 中没有点突变,而 18 株敏感的分离株则具有低 adeB 表达,且 gyrA 或 parC 中没有突变。携带 1 型整合子的 16 株(45.7%)对亚胺培南、阿米卡星、庆大霉素、头孢他啶或头孢吡肟的耐药性也高于无整合子的分离株。鲍曼不动杆菌中的 1 类整合子携带不同的耐药基因盒,包括 5'CS-bla(IMP-1)-aadA4-3'CS、5'CS-aacA4-aadA1-3'CS 和 5'CS-aacC1-aadA1-3'CS。总之,adeB 基因的表达与 A. baumannii 对环丙沙星和氨苄西林/舒巴坦的耐药性有关。gyrA 和 parC 的多重突变也在环丙沙星耐药中起作用。台湾鲍曼不动杆菌对亚胺培南耐药的主要金属β-内酰胺酶是 bla(IMP-1),它由 1 类整合子携带。1 类整合子与 A. baumannii 的 MDR 表型有关。

相似文献

1
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.台湾地区鲍曼不动杆菌临床分离株对环丙沙星、氨苄西林/舒巴坦和亚胺培南耐药机制的研究。
Int J Antimicrob Agents. 2010 Apr;35(4):382-6. doi: 10.1016/j.ijantimicag.2009.12.009. Epub 2010 Feb 6.
2
Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan.台湾地区携带1类整合子的多重耐药鲍曼不动杆菌菌株的传播情况
Clin Microbiol Infect. 2008 Nov;14(11):1010-9. doi: 10.1111/j.1469-0691.2008.02077.x.
3
Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.台湾地区不同基因组种属的对亚胺培南耐药不动杆菌分离株表型和基因型特征的差异。
Int J Antimicrob Agents. 2009 Dec;34(6):580-4. doi: 10.1016/j.ijantimicag.2009.06.027. Epub 2009 Sep 3.
4
[Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].[从临床样本中分离的鲍曼不动杆菌菌株中β-内酰胺酶相关耐药性的分子特征分析]
Mikrobiyol Bul. 2014 Jul;48(3):365-76.
5
High frequency of integrons related to drug-resistance in clinical isolates of Acinetobacter baumannii.鲍曼不动杆菌临床分离株中与耐药性相关的整合子频率较高。
Indian J Med Microbiol. 2011 Apr-Jun;29(2):118-23. doi: 10.4103/0255-0857.81784.
6
Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.台湾南部多重耐药鲍曼不动杆菌分离株的分子特征。
Int J Antimicrob Agents. 2011 Nov;38(5):403-8. doi: 10.1016/j.ijantimicag.2011.05.014. Epub 2011 Aug 26.
7
Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii.整合子在鲍曼不动杆菌对抗菌药物敏感性模式中的作用。
Jpn J Infect Dis. 2010 Nov;63(6):440-3.
8
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii.鲍曼不动杆菌暴发期间拓扑异构酶突变的选择及adeB mRNA转录本的过表达
J Antimicrob Chemother. 2004 Oct;54(4):821-3. doi: 10.1093/jac/dkh427. Epub 2004 Sep 8.
9
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.韩国除鲍曼不动杆菌外的碳青霉烯类耐药不动杆菌的特性。
Int J Antimicrob Agents. 2012 Jan;39(1):81-5. doi: 10.1016/j.ijantimicag.2011.08.006. Epub 2011 Oct 12.
10
[Investigation of presence of class 1 integrons in clinical isolates of carbapenem-resistant Acinetobacter baumannii].[耐碳青霉烯鲍曼不动杆菌临床分离株中1类整合子存在情况的调查]
Mikrobiyol Bul. 2010 Oct;44(4):547-52.

引用本文的文献

1
C7-Substituted Quinolines as Potent Inhibitors of AdeG Efflux Pumps in .C7-取代喹啉作为AdeG外排泵的强效抑制剂
ACS Infect Dis. 2025 Mar 14;11(3):626-638. doi: 10.1021/acsinfecdis.4c00705. Epub 2025 Feb 27.
2
Resensitization of Multi Drug-Resistant Aeromonas caviae with Exogenous Hydrogen Sulfide Potentiated Antibiotics.外源性硫化氢增强抗生素对多药耐药豚鼠气单胞菌的再敏化作用。
Curr Microbiol. 2024 Nov 23;82(1):4. doi: 10.1007/s00284-024-03985-2.
3
Epidemiology, resistance genomics and susceptibility of species: results from the 2020 Spanish nationwide surveillance study.
种的流行病学、耐药基因组学和易感性:来自 2020 年西班牙全国监测研究的结果。
Euro Surveill. 2024 Apr;29(15). doi: 10.2807/1560-7917.ES.2024.29.15.2300352.
4
A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant (CRAB) Isolates.新进展:舒巴坦/阿维巴坦联合用药增强舒巴坦对耐碳青霉烯类(CRAB)分离株的活性。
Antibiotics (Basel). 2021 May 13;10(5):577. doi: 10.3390/antibiotics10050577.
5
The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health.高度耐甲氧苄啶的二氢叶酸还原酶DfrB的细菌基因组背景凸显了对公共卫生的新威胁。
Antibiotics (Basel). 2021 Apr 13;10(4):433. doi: 10.3390/antibiotics10040433.
6
Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6')-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic : A 7-Year Single Center Study.外排泵的过表达、泵调节因子的突变、染色体突变以及AAC(6')-Ib-cr与新生儿败血症不同序列类型中的氟喹诺酮耐药性相关:一项7年的单中心研究。
Front Microbiol. 2021 Mar 11;12:602724. doi: 10.3389/fmicb.2021.602724. eCollection 2021.
7
Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in .细菌全基因组关联研究(bGWAS)和转录组学鉴定了……中的隐性抗菌耐药机制
Front Public Health. 2020 Sep 2;8:451. doi: 10.3389/fpubh.2020.00451. eCollection 2020.
8
AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant clinical isolates.耐环丙沙星临床分离株中 AdeR-AdeS 突变和 AdeABC 外排系统的过表达。
Indian J Med Res. 2018 Apr;147(4):413-421. doi: 10.4103/ijmr.IJMR_644_16.
9
Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China.中国不同遗传背景鲍曼不动杆菌分离株中舒巴坦耐药的分子流行病学和机制。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01947-17. Print 2018 Mar.
10
Active efflux pump adeB is involved in multidrug resistance of induced by antibacterial agents.主动外排泵adeB参与抗菌剂诱导的多重耐药性。
Exp Ther Med. 2017 Apr;13(4):1538-1546. doi: 10.3892/etm.2017.4141. Epub 2017 Feb 21.